ECOG-ACRIN Cancer Research Group

Home
United States
Philadelphia, PA
ECOG-ACRIN Cancer Research Group

Call Website

Biomarker-driven research involving adults who have or are at risk of developing cancer

10/23/2026

Do you have newly diagnosed glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here: https://bit.ly/gable-trial

10/22/2026

Do you have newly diagnosed multiple myeloma and are either ineligible for or willing to delay stem cell transplantation? If so, you may be eligible to participate in clinical trial EAA181/EQUATE. More info here: https://bit.ly/eaa181equate

10/22/2026

Monika Joshi, MD and Petros Grivas, MD, PhD are leading clinical trial EA8231, a phase 3 randomized trial comparing the effectiveness of pembrolizumab and sacituzumab govitecan to standard-of-care chemotherapy in patients with advanced urothelial cancer. https://bit.ly/ea8231-study

10/22/2026

Clinical study EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (HNSCC) that has come back after initial therapy. Learn more: https://bit.ly/ea3191-study

10/21/2026

Do you have early-stage and are age 75 or older? If so, you may be eligible to participate in this study of a potential new treatment approach. More info: https://bit.ly/ea6244-study

10/21/2026

Do you have advanced has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the study. Learn more: http://bit.ly/ComboMATCH

10/20/2026

A couple of highlights from the first day of our Fall 2026 Group Meeting: A Comis Translational Science Symposium focused on Inflammation as a Shared Mechanism Across Diseases; the Edith Peterson Mitchell, MD Travel Scholars.

10/20/2026

Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! Great session this morning!

10/20/2026

The study EA1242/RxFINE-Low is testing whether hormone therapy plus ribociclib, without chemotherapy, is as effective as standard treatment that includes chemotherapy. Learn more: https://bit.ly/ea1242-study

10/20/2026

The Fall 2026 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺

Address

Philadelphia, PA

Telephone

+12157893631

Website

http://ecog-acrin.org/, http://linktr.ee/ecog_acrin

Alerts

Be the first to know and let us send you an email when ECOG-ACRIN Cancer Research Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.